Authors
Latest:
Julie Harper, MD, to Present a Rosacea Research Roundup and PearlsShe shares her top 5 considerations for all dermatology drug prescribers.
Latest:
Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin HealthJeanine Downie, MD, FAAD, discussed critical updates on tattoo ink safety, new dermatologic technologies, biostimulators, and more at AAD 2025.
Latest:
Habits, Cultural Norms, and Rapid Advances In Technology Have Dramatically Changed the Aesthetic Medicine LandscapeAmy B. Lewis, MD, explores the evolution of aesthetic dermatology, delving into injection sophistication, devices, and top procedures.
Latest:
AI Model Shows Promise in Reducing Skin Cancer Detection BiasA novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or excessive hair.
Latest:
Jordan Miller, MD: 2024 Dermatology PredictionsAdvancements in assistance from artificial intelligence include ambient listening to take notes during physician and patient conversations.
Latest:
Efficacy and Safety of Laser Treatment for Patients With AcneA panelist discusses how laser treatments demonstrate a strong safety profile and proven efficacy for patients with acne, with clinical studies showing significant reduction in both inflammatory and noninflammatory lesions.
Latest:
Key Insights From the SPD Pre-AAD Meeting: Advances, Challenges, and the Future of Pediatric DermatologyMercedes E. Gonzalez, MD, reflects on the SPD meeting as well as challenges and advances in pediatric dermatology.
Latest:
The Dx and Rx of Congenital Malalignment Syndrome in ChildrenCongenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Latest:
Redefining Vitiligo Management: FDA-Approved Topical Ruxolitinib and the Evolving Treatment ParadigmPearl E. Grimes, MD, discusses the evolving treatment paradigm for vitiligo, highlighting the role of FDA-approved topical ruxolitinib and its impact on management strategies.
Latest:
Study Reveals Potential Genetic Connection Between Hidradenitis Suppurativa and Increased Risk of CAD and DiabetesOlder adults with higher genetic risk for HS show increased risks for coronary artery disease and diabetes, according to UK Biobank data.
Latest:
Jill Waibel, MD, FAAD: Innovations in Laser Modalities for the Treatment of ScarsWaibel shared pearls in laser therapy and other scar treatment modalities in her talks at the American Academy of Dermatology Annual Meeting.
Latest:
The Burden of AD Flares and Impact of Ruxolitinib Initiation on Utilization of Other TherapiesPosters at AMCP Nexus analyzed the burden of flares on patients with atopic dermatitis (AD) and the impact initiating ruxolitinib cream had on use of other therapies.
Latest:
85% of Survey Respondents Do Not Know What Actinic Keratosis IsThe survey conducted by Almirall included participants in the US and Europe.
Latest:
Pulsed Dye Lasers for Cosmetic ProceduresPulsed dye lasers are now being used for several different dermatologic conditions.
Latest:
Diamant Thaçi, MD, PhD: Understanding the Impact of Nemolizumab Efficacy Post Approvals in EU, UK, and SwitzerlandProfessor Diamant Thaçi, MD, PhD, discusses findings from the ARCADIA and OLYMPIA clinical trial programs, highlighting nemolizumab’s rapid efficacy in treating atopic dermatitis and prurigo nodularis.
Latest:
Artax Biopharma's AX-158: A Novel Approach to T Cell-Driven Inflammation in PsoriasisScott Batty, MD, and Chris VanDeusen, PhD, provided insights on AX-158's phase 2a results, presented at the SID Annual Meeting.
Latest:
New Tech for SkinThere are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
Latest:
Rare Immune Cell May Predict Immunotherapy Response in MelanomaVd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
Latest:
Topical Steroid Withdrawal: Uncovering Neuroinflammatory MechanismsOur May cover story explores NIH’s new findings on topical steroid withdrawal, a condition now under scientific scrutiny as a distinct entity.
Latest:
Addressing Causes of Female Hair Loss and Exploring Preventative MeasuresThis expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Latest:
Evolving Melanoma Outcomes and Care: Insights from Victor Gall, MDAs melanoma rates rise, Victor Gall, MD, emphasizes proactive care, early detection, and innovative treatments to improve patient outcomes and survival rates.
Latest:
Comparing Devices to Assess Facial Pigmentary and Inflammatory ConditionsPrecision measurements are necessary to improve the current therapeutic armamentarium in pigmentary disorders.
Latest:
Navigating Pregnancy, Dermatology, and Drug SafetyKatherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.
Latest:
Recognizing Topical Steroid Withdrawal and Advancing Therapeutic PrecisionAt RAD 2025, Brad Glick, DO, MPH, reviewed the clinical signs of topical steroid withdrawal, the need for detailed patient histories to distinguish it from severe AD flares, and the role of targeted non-steroidal and systemic therapies.
Latest:
What Lies Ahead for GPP Diagnosis and ManagementPanelists discuss how the future of generalized pustular psoriasis (GPP) diagnosis and management looks promising with emerging genetic testing for IL36RN mutations, development of multiple targeted biologics beyond IL-36 inhibitors, potential personalized treatment algorithms, improved disease classification, and enhanced multidisciplinary care approaches to better address this rare but severe dermatological condition.
